HB 346 – Kentucky
Status: Inactive / DeadYear Introduced: 2023
Link: https://apps.legislature.ky.gov/record/23rs/HB346.html
Amend KRS 304.17A-163 to permit insurers to require insureds to try biosimilar biological products prior to providing coverage for the equivalent branded prescription drug under certain circumstances; amend KRS 217.814 to define biosimilar biological product; amend KRS 217.822 to require dispensing of biosimilar biological products under certain circumstances.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found